610-29-7Relevant articles and documents
Delivery of oxaliplatin to colorectal cancer cells by folate-targeted UiO-66-NH2
Hashemzadeh, Alireza,Amerizadeh, Forouzan,Asgharzadeh, Fereshteh,Darroudi, Majid,Avan, Amir,Hassanian, Seyed Mahdi,Landarani, Mohammad,Khazaei, Majid
, (2021/05/27)
Oxaliplatin is being used in different malignancies and several side effects are reported for patients taking Oxaliplatin, including peripheral neuropathy, nausea and vomiting, diarrhea, mouth sores, low blood counts, fatigue, loss of appetite, etc. Here we have developed a targeted anticancer drug delivery system based on folate-conjugated amine-functionalized UiO-66 for the delivery of oxaliplatin (OX). UiO-66-NH2 (U) and UiO-66-NH2–FA(FU) were pre-functionalized by the incorporation of folic acid (FA) into the structure via coordination of the carboxylate group of FA. The FTIR spectra of drug-loaded U and FU showed the presence of new carboxylic and aliphatic groups of OX and FA. Powder X-ray diffraction (PXRD) patterns were matched accordingly with the reference pattern and FESEM results showed semi-spherical particles (115–128 nm). The evaluated amounts of OX in U and FU were calculated 304.5 and 293 mg/g, respectively. The initial burst release of OX was 15.7% per hour for U(OX) and 10.8% per hour for FU(OX). The final release plateau gives 62.9% and 52.3% for U(OX) and FU(OX). To evaluate the application of the prepared delivery platform, they were tested on colorectal cancer cells (CT-26) via MTT assay, cell migration assay, and spheroid model. IC50 values obtained from MTT assay were 21.38, 95.50, and 18.20 μg/mL for OX, U(OX), and FU(OX), respectively. After three days of treatment, the CT26 spheroids at two doses of 500 and 50 μg/mL of U(OX) and FU(OX) showed volume reduction. Moreover, the oxidative behavior of the prepared systems within the cell was assessed by total thiol, malondialdehyde, and superoxide dismutase activity. The results showed that FU(OX) had higher efficacy in preventing the growth of CT-26 spheroid, and was more effective than oxaliplation in cell migration inhibition, and induced higher oxidative stress and apoptosis.
Synthesis of bis(propargyl) aromatic esters and ethers: A potential replacement for isocyanate based curators
Sonawane, Sanjeevani H.,Anniyappan,Athar, Javaid,Banerjee, Shaibal,Sikder, Arun K.
, p. 8495 - 8502 (2016/02/05)
This study reports the synthesis and characterization of a novel class of non-isocyanate curing agents based on bis-propargyl aromatic esters 2a-e and ethers 4a-c. A total of eight non-isocyanate curators were prepared from the reaction of respective dicarboxy or dihydroxybenzene with propargyl bromide in the presence of potassium carbonate with good yields. The structure and purity of the synthesized compounds and the corresponding intermediates were confirmed by spectral (IR and NMR), thermal (DSC) and chromatographic techniques (HPLC & GC-MS). Furthermore, kinetics of the curing reaction between glycidyl azide polymer (GAP) and the synthesized alkynes (4b, 4c) were studied using time-resolved FT-IR spectroscopy as a function of time at 303, 323 and 333 K. It was found that the curing reaction was faster when the temperature was increased. Kinetic parameters of the curing reaction, such as the reaction order and activation energy, were calculated for the GAP-4a and GAP-4c systems. All the curing reactions followed first order kinetics and the corresponding activation energy of the curing reaction for the systems was found to be 15.56 and 13.22 kcal mol-1. For comparison, curing studies were performed for GAP with a conventional curator Desmodur N-100. GAP cured with non-isocyanate curators offered good mechanical properties compared to GAP cured with isocyanate (N-100). The advantage of these new curing systems is that they do not require catalyst and there is no need for specific environmental conditions. Based on these studies, 1,4-bis(2-propynyloxy)benzene (4b) has the most potential as a non-isocyanate curator for azide polymeric binders.
Inclusion complex containing epoxy resin composition for semiconductor encapsulation
-
, (2014/03/21)
The invention is an epoxy resin composition for sealing a semiconductor, including (A) an epoxy resin and (B) a clathrate complex. The clathrate complex is one of (b1) an aromatic carboxylic acid compound, and (b2) at least one imidazole compound represented by formula (II): wherein R2 represents a hydrogen atom, C1-C10 alkyl group, phenyl group, benzyl group or cyanoethyl group, and R3 to R5 represent a hydrogen atom, nitro group, halogen atom, C1-C20 alkyl group, phenyl group, benzyl group, hydroxymethyl group or C1-C20 acyl group. The composition has improved storage stability, retains flowability when sealing, and achieves an effective curing rate applicable for sealing delicate semiconductors.